{"name":"The Impact of Dementia on the Clinical Outcome of COVID-19: A Systematic Review and Meta-Analysis","id":"21","link":"https://content.iospress.com/articles/journal-of-alzheimers-disease/jad201016","dbsearches":"3","refs":"https://docs.google.com/spreadsheets/d/1sDLvLmM5j5qYArK18dfmE2ejhqJwpS8OsE94Z4_MKeg/edit#gid=0","references":[{"doi":"10.1093/gerona/glaa183","date":"1970-01-01","title":"Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort","abstract":"Background\nHospitalized COVID-19 patients tend to be older and frequently have hypertension, diabetes, or coronary heart disease, but whether these comorbidities are true risk factors (ie, more common than in the general older population) is unclear.\n\n We estimated associations between preexisting diagnoses and hospitalized COVID-19 alone or with mortality, in a large community cohort.\n\n\nMethods\nUK Biobank (England) participants with baseline assessment 2006–2010, followed in hospital discharge records to 2017 and death records to 2020. Demographic and preexisting common diagnoses association tested with hospitalized laboratory-confirmed COVID-19 (March 16 to April 26, 2020), alone or with mortality, in logistic models.\n\n\nResults\nOf 269 070 participants aged older than 65, 507 (0.2%) became COVID-19 hospital inpatients, of which 141 (27.8%) died.\n\n Common comorbidities in hospitalized inpatients were hypertension (59.6%), history of fall or fragility fractures (29.4%), coronary heart disease (21.5%), type 2 diabetes (type 2, 19. 9%), and asthma (17.6%).\n\n However, in models adjusted for comorbidities, age group, sex, ethnicity, and education, preexisting diagnoses of dementia, type 2 diabetes, chronic obstructive pulmonary disease, pneumonia, depression, atrial fibrillation, and hypertension emerged as independent risk factors for COVID-19 hospitalization, the first 5 remaining statistically significant for related mortality.\n\n Chronic kidney disease and asthma were risk factors for COVID-19 hospitalization in women but not men.\n\n\nConclusions\nThere are specific high-risk preexisting comorbidities for COVID-19 hospitalization and related deaths in community-based older men and women.\n\n These results do not support simple age-based targeting of the older population to prevent severe COVID-19 infections.\n\n\n","id":"PMC7454409","idformat":"PMC","foundapis":"_PMC_CROSSREF","miscinfo":"","authors":[{"firstname":"Janice L","surname":"Atkins","email":"NULL","contributions":"1"},{"firstname":"Jane A H","surname":"Masoli","email":"NULL","contributions":"2"},{"firstname":"Jane A H","surname":"Masoli","email":"NULL","contributions":"0"},{"firstname":"Joao","surname":"Delgado","email":"NULL","contributions":"2"},{"firstname":"Joao","surname":"Delgado","email":"NULL","contributions":"0"},{"firstname":"Luke C","surname":"Pilling","email":"NULL","contributions":"2"},{"firstname":"Luke C","surname":"Pilling","email":"NULL","contributions":"0"},{"firstname":"Chia-Ling","surname":"Kuo","email":"NULL","contributions":"2"},{"firstname":"Chia-Ling","surname":"Kuo","email":"NULL","contributions":"0"},{"firstname":"George A","surname":"Kuchel","email":"NULL","contributions":"2"},{"firstname":"George A","surname":"Kuchel","email":"NULL","contributions":"0"},{"firstname":"David","surname":"Melzer","email":"D.Melzer@exeter.ac.uk","contributions":"1"},{"firstname":"Anne B","surname":"Newman","email":"NULL","contributions":"2"},{"firstname":"                          Anne B","surname":"Newman","email":"NULL","contributions":"0"}]},{"doi":"10.1007/s12603-020-1389-1","date":"2020-05-11","title":"Clinical Presentation of COVID19 in Dementia Patients","abstract":"Objective\nNo studies analyzing the role of dementia as a risk factor for mortality in patients affected by COVID-19. We assessed the prevalence, clinical presentation and outcomes of dementia among subjects hospitalized for COVID19 infection.\n\n\nDesign\nRetrospective study.\n\n\nSetting\nCOVID wards in Acute Hospital in Brescia province, Northern Italy.\n\n\nParticipants\nWe used data from 627 subjects admitted to Acute Medical wards with COVID 19 pneumonia.\n\n\nMeasurements\nClinical records of each patients admitted to the hospital with a diagnosis of COVID19 infection were retrospectively analyzed.\n\n Diagnosis of dementia, modalities of onset of the COVID-19 infection, symptoms of presentation at the hospital and outcomes were recorded.\n\n\nResults\nDementia was diagnosed in 82 patients (13.1%).\n\n The mortality rate was 62.2% (51/82) among patients affected by dementia compared to 26.2% (143/545) in subjects without dementia (p&lt;0.001, Chi-Squared test).\n\n In a logistic regression model age, and the diagnosis of dementia resulted independently associated with a higher mortality, and patients diagnosed with dementia presented an OR of 1.84 (95% CI: 1.09–3.13, p&lt;0.05).\n\n Among patients diagnosed with dementia the most frequent symptoms of onset were delirium, especially in the hypoactive form, and worsening of the functional status.\n\n\nConclusion\nThe diagnosis of dementia, especially in the most advanced stages, represents an important risk factor for mortality in COVID-19 patients.\n\n The clinical presentation of COVID-19 in subjects with dementia is atypical, reducing early recognition of symptoms and hospitalization.\n\n\n","id":"PMC7227170","idformat":"PMC","foundapis":"_PMC_Springer_CROSSREF","miscinfo":"","authors":[{"firstname":"Angelo","surname":"Bianchetti","email":"angelo.bianchetti@grupposandonato.it","contributions":"1"},{"firstname":"R.","surname":"Rozzini","email":"NULL","contributions":"1"},{"firstname":"F.","surname":"Guerini","email":"NULL","contributions":"1"},{"firstname":"S.","surname":"Boffelli","email":"NULL","contributions":"1"},{"firstname":"P.","surname":"Ranieri","email":"NULL","contributions":"1"},{"firstname":"G.","surname":"Minelli","email":"NULL","contributions":"1"},{"firstname":"L.","surname":"Bianchetti","email":"NULL","contributions":"1"},{"firstname":"                          M.","surname":"Trabucchi","email":"NULL","contributions":"1"}]},{"doi":"10.18632/aging.103371","date":"2020-05-14","title":"Prognosis analysis of patients with mental disorders with COVID-19: a single-center retrospective study","abstract":"Our study aimed to investigate the factors affecting the prognosis of patients with mental disorders with COVID-19. All patients with mental disorders who were diagnosed with COVID-19 at the intensive care unit of Wuhan Mental Health Center during the period January 3 to March 1, 2020 were selected.\n\n The influence of the baseline characteristics, clinical symptoms, laboratory parameters and the types of mental disorders on prognosis were analyzed.\n\n According to their final prognosis, the patients were divided into the deceased group (5 patients) and the cured group (25 patients).\n\n The mortality rate of patients with dementia was significantly higher than that of patients with other mental disorders (P = 0.001).\n\n The levels of certain laboratory parameters in the serum of dementia patients were significantly increased compared with levels in nondementia patients (WBC count: 10.100±6.147 vs.\n\n 5.694±3.383, p = 0.029; neutrophil count: 8.504± 5.993 vs.\n\n 3.764 ± 2.733, P = 0.008; BUN: 8.300± 4.072 vs.\n\n 4.364 ± 1.196, P = 0.001).\n\n Our research indicated that the mortality rate of dementia patients with COVID-19 was higher than that of patients with other mental disorders.\n\n A focus on the inflammatory response of dementia patients may provide novel ideas for reducing mortality.\n\n","id":"PMC7343444","idformat":"PMC","foundapis":"_PMC_CROSSREF","miscinfo":"","authors":[{"firstname":"Yan","surname":"Wan","email":"NULL","contributions":"1"},{"firstname":"Juan","surname":"Wu","email":"NULL","contributions":"1"},{"firstname":"Lihua","surname":"Ni","email":"NULL","contributions":"1"},{"firstname":"Qinqin","surname":"Luo","email":"NULL","contributions":"1"},{"firstname":"Cheng","surname":"Yuan","email":"NULL","contributions":"1"},{"firstname":"Fang","surname":"Fan","email":"NULL","contributions":"1"},{"firstname":"Hong","surname":"Liu","email":"NULL","contributions":"0"},{"firstname":"Changjiang","surname":"Zhang","email":"NULL","contributions":"1"},{"firstname":"Yuandi","surname":"Xiang","email":"NULL","contributions":"1"},{"firstname":"                          Qin","surname":"Xie","email":"NULL","contributions":"1"}]},{"doi":"10.1016/j.jamda.2020.06.008","date":"1970-01-01","title":"Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study","abstract":"Objectives\nTo determine the association between frailty and short-term mortality in older adults hospitalized for coronavirus disease 2019 (COVID-19).\n\n\nDesign\nRetrospective single-center observational study.\n\n\nSetting and participants\nEighty-one patients with COVID-19 confirmed by reverse-transcriptase polymerase chain reaction (RT-PCR), at the Geriatrics department of a general hospital in Belgium.\n\n\nMeasurements\nFrailty was graded according to the Rockwood Clinical Frailty Scale (CFS).\n\n Demographic, biochemical, and radiologic variables, comorbidities, symptoms, and treatment were extracted from electronic medical records.\n\n\nResults\nParticipants (N = 48 women, 59%) had a median age of 85 years (range 65-97 years) and a median CFS score of 7 (range 2-9); 42 (52%) were long-term care residents.\n\n Within 6 weeks, 18 patients died.\n\n Mortality was significantly but weakly associated with age (Spearman r = 0.241, P = .\n\n03) and CFS score (r = 0.282, P = .\n\n011), baseline lactate dehydrogenase (LDH; r = 0.301, P = .\n\n009), lymphocyte count (r = ?0.262, P = .\n\n02), and RT-PCR cycle threshold (Ct, r = ?0.285, P = .\n\n015).\n\n Mortality was not associated with long-term care residence, dementia, delirium, or polypharmacy.\n\n In multivariable logistic regression analyses, CFS, LDH, and RT-PCR Ct (but not age) remained independently associated with mortality.\n\n Both age and frailty had poor specificity to predict survival.\n\n A multivariable model combining age, CFS, LDH, and viral load significantly predicted survival.\n\n\nConclusions and Implications\nAlthough their prognosis is worse, even the oldest and most severely frail patients may benefit from hospitalization for COVID-19, if sufficient resources are available.\n\n\n","id":"PMC7280137","idformat":"PMC","foundapis":"_PMC_elsevier_CROSSREF","miscinfo":"","authors":[{"firstname":"Robert","surname":"De Smet","email":"NULL","contributions":"1"},{"firstname":"Bea","surname":"Mellaerts","email":"NULL","contributions":"1"},{"firstname":"Hannelore","surname":"Vandewinckele","email":"NULL","contributions":"1"},{"firstname":"Peter","surname":"Lybeert","email":"NULL","contributions":"1"},{"firstname":"Eric","surname":"Frans","email":"NULL","contributions":"1"},{"firstname":"Sara","surname":"Ombelet","email":"NULL","contributions":"1"},{"firstname":"Wim","surname":"Lemahieu","email":"NULL","contributions":"1"},{"firstname":"Rolf","surname":"Symons","email":"NULL","contributions":"3"},{"firstname":"Erwin","surname":"Ho","email":"NULL","contributions":"1"},{"firstname":"Johan","surname":"Frans","email":"NULL","contributions":"2"},{"firstname":"Annick","surname":"Smismans","email":"NULL","contributions":"1"},{"firstname":"                          Michaël R.","surname":"Laurent","email":"NULL","contributions":"1"}]},{"doi":"10.1111/ggi.13960","date":"2020-05-18","title":"Clinical characteristics and prognostic factors in COVID?19 patients aged ?80?years","abstract":"Aim\nThe aim of the present study was to describe the clinical presentation of patients aged ?80?years with coronavirus disease 2019 (COVID?19), and provide insights regarding the prognostic factors and the risk stratification in this population.\n\n\nMethods\nThis was a single?center, retrospective, observational study, carried out in a referral center for COVID?19 in central Italy.\n\n We reviewed the clinical records of patients consecutively admitted for confirmed COVID?19 over a 1?month period (1–31 March 2020).\n\n We excluded asymptomatic discharged patients.\n\n We identified risk factors for death, by a uni? and multivariate Cox regression analysis.\n\n To improve model fitting and hazard estimation, continuous parameters where dichotomized by using Youden’s index.\n\n\nResults\nOverall, 69 patients, aged 80–98?years, met the inclusion criteria and were included in the study cohort.\n\n The median age was 84?years (82–89?years is interquartile range); 37 patients (53.6%) were men.\n\n Globally, 14 patients (20.3%) presented a mild, 30 (43.5%) a severe and 25 (36.2%) a critical COVID?19 disease.\n\n A total of 23 (33.3%) patients had died at 30?days’ follow up.\n\n Multivariate Cox regression analysis showed that severe dementia, pO2 ?90 at admission and lactate dehydrogenase &gt;464?U/L were independent risk factors for death.\n\n\nConclusions\nThe present data suggest that risk of death could be not age dependent in patients aged ?80?years, whereas severe dementia emerged is a relevant risk factor in this population.\n\n Severe COVID?19, as expressed by elevated lactate dehydrogenase and low oxygen saturation at emergency department admission, is associated with a rapid progression to death in these patients.\n\n Geriatr Gerontol Int 2020; ••: ••–••.\n\n\n","id":"PMC7300699","idformat":"PMC","foundapis":"_PMC_CROSSREF","miscinfo":"","authors":[{"firstname":"Marcello","surname":"Covino","email":"marcello.covino@policlinicogemelli.it","contributions":"2"},{"firstname":"Giuseppe","surname":"De Matteis","email":"NULL","contributions":"2"},{"firstname":"Giuseppe","surname":"De Matteis","email":"NULL","contributions":"0"},{"firstname":"Michele","surname":"Santoro","email":"NULL","contributions":"1"},{"firstname":"Luca","surname":"Sabia","email":"NULL","contributions":"1"},{"firstname":"Benedetta","surname":"Simeoni","email":"NULL","contributions":"1"},{"firstname":"Marcello","surname":"Candelli","email":"NULL","contributions":"1"},{"firstname":"Veronica","surname":"Ojetti","email":"NULL","contributions":"1"},{"firstname":"                          Francesco","surname":"Franceschi","email":"NULL","contributions":"1"}]},{"doi":"10.1002/jmv.26337","date":"2020-07-17","title":"Risk factors and outcomes of COVID?19 in New York City; a retrospective cohort study","abstract":"Coronavirus disease 2019 (COVID?19) is a global pandemic and information on risk factors for worse prognosis is needed to accurately identify patients at risk and potentially provide insight into therapeutic options.\n\n In this retrospective cohort study, including 3703 patients with laboratory confirmed COVID?19, we identified risk factors associated with all?cause mortality, need for hospitalization and mechanical ventilation.\n\n Male gender was independently associated with increased risk of hospitalization (adjusted odds ratio [ORadj]: 1.62; 95% confidence interval [95% CI]: 1.38?1.91)), mechanical ventilation (ORadj: 1.35; 95% CI: 1.08?1.69) and death (ORadj: 1.46; 95% CI: 1.17?1.82).\n\n Patients &gt;?60 years had higher risk of hospitalization (ORadj: 5.47; 95% CI: 4.29?6.96), mechanical ventilation (ORadj: 3.26; 95% CI: 2.08?5.11) and death (ORadj: 13.04; 95% CI: 6.25?27.24).\n\n Congestive heart failure (ORadj: 1.47; 95% CI: 1.06?2.02) and dementia (ORadj: 2.03; 95% CI: 1.46?2.83) were associated with increased odds of death, as well as the presence of more than two comorbidities (ORadj: 1.90; 95% CI: 1.35?2.68).\n\n Patients with COVID?19 of older age, male gender, or having more than two comorbidities are at higher risk of hospitalization, mechanical ventilation and death, and should therefore be closely monitored.\n\n","id":"PMC7404409","idformat":"PMC","foundapis":"_PMC_CROSSREF","miscinfo":"","authors":[{"firstname":"Maaike","surname":"van Gerwen","email":"maaike.vangerwen@mountsinai.org","contributions":"1"},{"firstname":"Mathilda","surname":"Alsen","email":"NULL","contributions":"2"},{"firstname":"Mathilda","surname":"Alsen","email":"NULL","contributions":"0"},{"firstname":"Christine","surname":"Little","email":"NULL","contributions":"1"},{"firstname":"Joshua","surname":"Barlow","email":"NULL","contributions":"1"},{"firstname":"Eric","surname":"Genden","email":"NULL","contributions":"1"},{"firstname":"Leonard","surname":"Naymagon","email":"NULL","contributions":"1"},{"firstname":"                          Douglas","surname":"Tremblay","email":"NULL","contributions":"1"}]},{"doi":"10.1007/s10072-020-04541-z","date":"2020-06-21","title":"Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study","abstract":"Introduction\nIn the current study, we evaluated factors that increase the coronavirus disease (COVID-19) patient death rate by analyzing the data from two cohort hospitals.\n\n In addition, we studied whether underlying neurological diseases are risk factors for death.\n\n\nMethods\nIn this retrospective cohort study, we included 103 adult inpatients (aged ??18 years).\n\n We evaluated differences in demographic data between surviving and non-surviving COVID-19 patients.\n\n\nResults\nIn a multivariate logistic analysis, age and the presence of chronic lung disease and Alzheimer’s dementia (AD) were the only significant parameters for predicting COVID-19 non-survival (p?&lt;?0.05).\n\n However, hypertension, coronary vascular disease, dyslipidemia, chronic kidney disease, diabetes, and history of taking angiotensin II receptor blockers (ARBs) or angiotensin-converting enzyme (ACE) inhibitors, as well as nonsteroidal anti-inflammatory drugs (NSAIDs), were not significantly associated with the death of COVID-19 patients.\n\n The optimal cutoff value obtained from the maximum Youden index was 70 (sensitivity, 80.77%; specificity, 61.04%), and the odds ratio of non-survival increased 1.055 fold for every year of age.\n\n\nConclusions\nClinicians should closely monitor and manage the symptoms of COVID-19 patients who are over the age of 70 years or have chronic lung disease or AD.\n\n\n","id":"PMC7342552","idformat":"PMC","foundapis":"_PMC_Springer_CROSSREF","miscinfo":"","authors":[{"firstname":"Jong-moon","surname":"Hwang","email":"NULL","contributions":"0"},{"firstname":"Ju-Hyun","surname":"Kim","email":"NULL","contributions":"1"},{"firstname":"Jin-Sung","surname":"Park","email":"NULL","contributions":"1"},{"firstname":"Min Cheol","surname":"Chang","email":"wheel633@ynu.ac.kr","contributions":"1"},{"firstname":"                          Donghwi","surname":"Park","email":"bdome@hanmail.net","contributions":"1"}]},{"doi":"10.1038/s41467-021-21100-y","date":"2021-01-07","title":"The natural history of symptomatic COVID-19 during the first wave in Catalonia","abstract":"The natural history of coronavirus disease 2019 (COVID-19) has yet to be fully described.\n\n Here, we use patient-level data from the Information System for Research in Primary Care (SIDIAP) to summarise COVID-19 outcomes in Catalonia, Spain.\n\n We included 5,586,521 individuals from the general population.\n\n Of these, 102,002 had an outpatient diagnosis of COVID-19, 16,901 were hospitalised with COVID-19, and 5273 died after either being diagnosed or hospitalised with COVID-19 between 1st March and 6th May 2020. Older age, being male, and having comorbidities were all generally associated with worse outcomes.\n\n These findings demonstrate the continued need to protect those at high risk of poor outcomes, particularly older people, from COVID-19 and provide appropriate care for those who develop symptomatic disease.\n\n While risks of hospitalisation and death were lower for younger populations, there is a need to limit their role in community transmission.\n\n","id":"PMC7858639","idformat":"PMC","foundapis":"_PMC_Springer_CROSSREF","miscinfo":"","authors":[{"firstname":"Edward","surname":"Burn","email":"NULL","contributions":"1"},{"firstname":"Cristian","surname":"Tebé","email":"NULL","contributions":"2"},{"firstname":"Cristian","surname":"Tebé","email":"NULL","contributions":"0"},{"firstname":"Sergio","surname":"Fernandez-Bertolin","email":"NULL","contributions":"1"},{"firstname":"Maria","surname":"Aragon","email":"NULL","contributions":"1"},{"firstname":"Martina","surname":"Recalde","email":"NULL","contributions":"2"},{"firstname":"Martina","surname":"Recalde","email":"NULL","contributions":"0"},{"firstname":"Elena","surname":"Roel","email":"NULL","contributions":"1"},{"firstname":"Albert","surname":"Prats-Uribe","email":"NULL","contributions":"2"},{"firstname":"Albert","surname":"Prats-Uribe","email":"NULL","contributions":"0"},{"firstname":"Daniel","surname":"Prieto-Alhambra","email":"daniel.prietoalhambra@ndorms.ox.ac.uk","contributions":"2"},{"firstname":"Daniel","surname":"Prieto-Alhambra","email":"daniel.prietoalhambra@ndorms.ox.ac.uk","contributions":"0"},{"firstname":"Talita","surname":"Duarte-Salles","email":"NULL","contributions":"2"},{"firstname":"                          Talita","surname":"Duarte-Salles","email":"NULL","contributions":"0"}]},{"doi":"10.1371/journal.pone.0238281","date":"2020-08-13","title":"Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia, Italy","abstract":"This is a population-based prospective cohort study on archive data describing the age- and sex-specific prevalence of COVID-19 and its prognostic factors.\n\n All 2653 symptomatic patients tested positive for SARS-CoV-2 from February 27 to April 2, 2020 in the Reggio Emilia province, Italy, were included.\n\n COVID-19 cumulative incidence, hospitalization and death rates, and adjusted hazard ratios (HR) with 95% confidence interval (95% CI) were calculated according to sociodemographic and clinical characteristics.\n\n Females had higher prevalence of infection than males below age 50 (2.61 vs.\n\n 1.84 ‰), but lower in older ages (16.49 vs.\n\n 20.86 ‰ over age 80).\n\n Case fatality rate reached 20.7% in cases with more than 4 weeks follow up.\n\n After adjusting for age and comorbidities, men had a higher risk of hospitalization (HR 1.4 95% CI 1.2 to 1.6) and of death (HR 1.6, 95% CI 1.2 to 2.1).\n\n Patients over age 80 compared to age &lt; 50 had HR 7.1 (95% CI 5.4 to 9.3) and HR 27.8 (95% CI 12.5 to 61.7) for hospitalization and death, respectively.\n\n Immigrants had a higher risk of hospitalization (HR 1.3, 95% CI 0.99 to 1.81) than Italians and a similar risk of death.\n\n Risk of hospitalization and of death were higher in patients with heart failure, arrhythmia, dementia, coronary heart disease, diabetes, and hypertension, while COPD increased the risk of hospitalization (HR 1.9, 95% CI 1.4 to 2.5) but not of death (HR 1.1, 95% CI 0.7 to 1.7).\n\n Previous use of ACE inhibitors had no effect on risk of death (HR 0.97, 95% CI 0.69 to 1.34).\n\n Identified susceptible populations and fragile patients should be considered when setting priorities in public health planning and clinical decision making.\n\n","id":"PMC7451640","idformat":"PMC","foundapis":"_PMC_CROSSREF","miscinfo":"","authors":[{"firstname":"Paolo","surname":"Giorgi Rossi","email":"NULL","contributions":"0"},{"firstname":"Massimiliano","surname":"Marino","email":"NULL","contributions":"1"},{"firstname":"Debora","surname":"Formisano","email":"NULL","contributions":"1"},{"firstname":"Francesco","surname":"Venturelli","email":"NULL","contributions":"1"},{"firstname":"Massimo","surname":"Vicentini","email":"NULL","contributions":"2"},{"firstname":"Massimo","surname":"Vicentini","email":"NULL","contributions":"0"},{"firstname":"Roberto","surname":"Grilli","email":"NULL","contributions":"1"},{"firstname":"NULL","surname":"NULL","email":"NULL","contributions":"0"},{"firstname":"Gianluigi","surname":"Forloni","email":"NULL","contributions":"8"},{"firstname":"Gianluigi","surname":"Forloni","email":"NULL","contributions":"0"},{"firstname":"Gianluigi","surname":"Forloni","email":"NULL","contributions":"0"},{"firstname":"Gianluigi","surname":"Forloni","email":"NULL","contributions":"0"},{"firstname":"Gianluigi","surname":"Forloni","email":"NULL","contributions":"0"},{"firstname":"Gianluigi","surname":"Forloni","email":"NULL","contributions":"0"},{"firstname":"Gianluigi","surname":"Forloni","email":"NULL","contributions":"0"},{"firstname":"                          Gianluigi","surname":"Forloni","email":"NULL","contributions":"0"}]},{"doi":"10.1016/j.psychres.2020.113028","date":"1970-01-01","title":"Facetime to reduce behavioral problems in a nursing home resident with Alzheimer's dementia during COVID-19","abstract":"","id":"PMC7177115","idformat":"PMC","foundapis":"_PMC_elsevier_CROSSREF","miscinfo":"","authors":[{"firstname":"Sanjana P.","surname":"Padala","email":"NULL","contributions":"1"},{"firstname":"Ashlyn M.","surname":"Jendro","email":"NULL","contributions":"1"},{"firstname":"                          Lillian C.","surname":"Orr","email":"Lillian.Orr@va.gov","contributions":"1"}]}]}